Rezultati - Christi J. van Asperen

Refine Results
  1. 1
    Cancer risks in BRCA2 families: estimates for sites other than breast and ovary

    Cancer risks in BRCA2 families: estimates for sites other than breast and ovary od Christi J. van Asperen

    Izdano 2005
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life

    The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life od Joël Vos, Wilma Otten, Christi J. van Asperen, Anna Jansen, Fred H. Menko, Aad Tibben

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives

    A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives od Joël Vos, Fred H. Menko, Anna M. Jansen, Christi J. van Asperen, Anne M. Stiggelbout, Aad Tibben

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Clinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cancer

    Clinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cance... od Sandra van Dijk, Daniëlle R. M. Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J. van Asperen, Wilma Otten

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany

    Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany od Dorothea Gadzicki, D. Gareth Evans, Hilary Harris, Claire Julian‐Reynier, Irmgard Nippert, Jörg Schmidtke, Aad Tibben, Christi J. van Asperen, Brigitte Schlegelberger

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome?

    Next-Generation Diagnostics: Gene Panel, Exome, or Whole Genome? od Yu Sun, Claudia Ruivenkamp, Mariëtte J.V. Hoffer, Terry Vrijenhoek, Marjolein Kriek, Christi J. van Asperen, Johan T. den Dunnen, Gijs W.E. Santen

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members

    Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members od Eveline M. A. Bleiker, Neil K. Aaronson, Fred H. Menko, Daniela Hahn, Christi J. van Asperen, Emiel J. Rutgers, Leo P. ten Kate, N. J. Leschot

    Izdano 1997
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    The functional impact of variants of uncertain significance in BRCA2

    The functional impact of variants of uncertain significance in BRCA2 od Romy L.S. Mesman, Fabienne M.G.R. Calléja, Giel Hendriks, Bruno Morolli, Branislav Mišovic, Peter Devilee, Christi J. van Asperen, Harry Vrieling, Maaike P.G. Vreeswijk

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Intronic variants in<i>BRCA1</i>and<i>BRCA2</i>that affect RNA splicing can be reliably selected by splice-site prediction programs

    Intronic variants in<i>BRCA1</i>and<i>BRCA2</i>that affect RNA splicing can be reliably selected by splice-site prediction programs od Maaike P.G. Vreeswijk, Jaco Kraan, Heleen M. van der Klift, Geraldine R. Vink, Cees J. Cornelisse, Juul Wijnen, Egbert Bakker, Christi J. van Asperen, Peter Devilee

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Recommendations for reporting results of diagnostic genomic testing

    Recommendations for reporting results of diagnostic genomic testing od Zandra C. Deans, Joo Wook Ahn, Isabel M. Carreira, Elisabeth Dequeker, Mick Henderson, Luca Lovrečić, Katrin Õunap, Melody Tabiner, Rebecca J. L. Treacy, Christi J. van Asperen

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

    Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers od T.C. van Sprundel, Marjanka K. Schmidt, Matti A. Rookus, Richard M. Brohet, Christi J. van Asperen, Emiel J. Rutgers, Laura J. vanʼt Veer, Rob A.�E.�M. Tollenaar

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial

    Effectiveness and cost-effectiveness of meaning-centered group psychotherapy in cancer survivors: protocol of a randomized controlled trial od Nadia van der Spek, Joël Vos, Cornelia F. van Uden–Kraan, William Breitbart, Pim Cuijpers, Kitty Knipscheer-Kuipers, Vincent Willemsen, Rob A.�E.�M. Tollenaar, Christi J. van Asperen, Irma M. Verdonck‐de Leeuw

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i>breast cancer families

    Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-<i>BRCA1/2</i>breast cancer families od Inge M. M. Lakeman, Florentine Hilbers, Mar Rodríguez‐Girondo, Andrew Lee, Maaike P.G. Vreeswijk, Antoinette Hollestelle, Caroline Seynaeve, Hanne Meijers‐Heijboer, Jan C. Oosterwijk, Nicoline Hoogerbrugge, Edith Oláh, Hans F. A. Vasen, Christi J. van Asperen, Peter Devilee

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

    Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program od Marijn A. Vermeulen, Leen Slaets, Fátima Cardoso, Sharon H. Giordano, Konstantinos Tryfonidis, P. J. van Diest, N Dijkstra, Carolien P. Schröder, Christi J. van Asperen, Barbro Linderholm, Kim Benstead, Renée Foekens, John W.M. Martens, John M.S. Bartlett, Carolien H. M. van Deurzen

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

    Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases od Petra E.A. Huijts, Maaike P.G. Vreeswijk, Karin Kroeze‐Jansema, Catharina E. Jacobi, Caroline Seynaeve, Elly MM Krol-Warmerdam, Pauline M. Wijers‐Koster, Jannet Blom, Karen A. Pooley, Jan G.M. Klijn, Rob A.�E.�M. Tollenaar, Peter Devilee, Christi J. van Asperen

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    A Genotypic and Histopathological Study of a Large Dutch Kindred with Hyperparathyroidism-Jaw Tumor Syndrome1

    A Genotypic and Histopathological Study of a Large Dutch Kindred with Hyperparathyroidism-Jaw Tumor Syndrome1 od Carola J. Haven, Fung Ki Wong, Eveline W. C. M. van Dam, Rob B. van der Luijt, Christi J. van Asperen, Joke Jansen, Carla Rosenberg, Mireille de Wit, Janine Roijers, Jo W.M. Höppener, Cornelis J.M. Lips, Catharina Larsson, Bin Tean Teh, Hans Morreau

    Izdano 2000
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Germline <i>BRCA</i>-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

    Germline <i>BRCA</i>-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity od Marthe M. de Jonge, Lauren L. Ritterhouse, Cor D. de Kroon, Maaike P.G. Vreeswijk, Jeremy P. Segal, Rutika Puranik, Harry Hollema, Matti A. Rookus, Christi J. van Asperen, Flora E. van Leeuwen, Vincent T.H.B.M. Smit, Brooke E. Howitt, Tjalling Bosse

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers

    Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers od Anouk Pijpe, Peggy Manders, Richard M. Brohet, J. Margriet Collée, Senno Verhoef, Hans F. A. Vasen, Nicoline Hoogerbrugge, Christi J. van Asperen, Charlotte J. Dommering, Margreet G.E.M. Ausems, Cora M. Aalfs, E. Gómez, Laura J. vanʼt Veer, Flora E. van Leeuwen, Matti A. Rookus

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients

    Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients od Ettore Capoluongo, Gillian Ellison, José Antonio López‐Guerrero, Frédérique Penault‐Llorca, Marjolijn J. L. Ligtenberg, Susana Banerjee, Christian F. Singer, Eitan Friedman, Birgid Markiefka, Peter Schirmacher, Reinhard Büttner, Christi J. van Asperen, Isabelle Ray‐Coquard, Volker Endris, Suzanne Kamel‐Reid, Natalie Percival, Jane Bryce, Benno Röthlisberger, Richie Soong, David González de Castro

    Izdano 2017
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

    Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases od Inge M. M. Lakeman, Mar D M Rodríguez-Girondo, Andrew Lee, Nandi Celosse, Merel E. Braspenning, Klaartje van Engelen, Irma van de Beek, Annemiek H van der Hout, E. Gómez, Arjen R. Mensenkamp, Margreet G.E.M. Ausems, Maartje J. Hooning, Muriel A. Adank, Antoinette Hollestelle, Marjanka K. Schmidt, Christi J. van Asperen, Peter Devilee

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: